600 related articles for article (PubMed ID: 18616554)
1. Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes.
Zachry WM; Doan QD; Clewell JD; Smith BJ
Epilepsia; 2009 Mar; 50(3):493-500. PubMed ID: 18616554
[TBL] [Abstract][Full Text] [Related]
2. Effects of antiepileptic drug substitutions on epileptic events requiring acute care.
Rascati KL; Richards KM; Johnsrud MT; Mann TA
Pharmacotherapy; 2009 Jul; 29(7):769-74. PubMed ID: 19558250
[TBL] [Abstract][Full Text] [Related]
3. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS
Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
Davis KL; Candrilli SD; Edin HM
Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549
[TBL] [Abstract][Full Text] [Related]
5. Acute epilepsy exacerbations in patients switched between A-rated anti-epileptic drugs.
Devine ST; Weisbart E; Barron J; Behm A
Curr Med Res Opin; 2010 Feb; 26(2):455-63. PubMed ID: 20014974
[TBL] [Abstract][Full Text] [Related]
6. Association between antiepileptic drug switching and epilepsy-related events.
Hansen RN; Campbell JD; Sullivan SD
Epilepsy Behav; 2009 Aug; 15(4):481-5. PubMed ID: 19615948
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalent antiepileptic drug switching and the risk of seizure-related events.
Hansen RN; Nguyen HP; Sullivan SD
Epilepsy Res; 2013 Sep; 106(1-2):237-43. PubMed ID: 23726541
[TBL] [Abstract][Full Text] [Related]
8. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.
Perucca E; Albani F; Capovilla G; Bernardina BD; Michelucci R; Zaccara G
Epilepsia; 2006; 47 Suppl 5():16-20. PubMed ID: 17239100
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy.
Erickson SC; Le L; Ramsey SD; Solow BK; Zakharyan A; Stockl KM; Harada AS; Curtis B
Epilepsia; 2011 Jul; 52(7):1365-71. PubMed ID: 21692778
[TBL] [Abstract][Full Text] [Related]
10. Economic burden associated with the use of generic antiepileptic drugs in the United States.
Helmers SL; Paradis PE; Manjunath R; Duh MS; Lafeuille MH; Latrémouille-Viau D; Lefebvre P; Labiner DM
Epilepsy Behav; 2010 Aug; 18(4):437-44. PubMed ID: 20580619
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy.
Ettinger AB; Manjunath R; Candrilli SD; Davis KL
Epilepsy Behav; 2009 Feb; 14(2):324-9. PubMed ID: 19028602
[TBL] [Abstract][Full Text] [Related]
12. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
Shinnar S; Pellock JM; Conry JA
Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
[TBL] [Abstract][Full Text] [Related]
13. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.
Duh MS; Cahill KE; Paradis PE; Cremieux PY; Greenberg PE
Expert Opin Pharmacother; 2009 Oct; 10(14):2317-28. PubMed ID: 19663636
[TBL] [Abstract][Full Text] [Related]
14. Changes in medication associated with epilepsy-related hospitalisation: a case-crossover study.
Handoko KB; Zwart-van Rijkom JE; Hermens WA; Souverein PC; Egberts TC
Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):189-96. PubMed ID: 17036373
[TBL] [Abstract][Full Text] [Related]
15. [The clinical and economic impact of generic drugs in the treatment of epilepsy].
Argumosa A; Herranz JL
Rev Neurol; 2005 Jul 1-15; 41(1):45-9. PubMed ID: 15999330
[TBL] [Abstract][Full Text] [Related]
16. Generic products of antiepileptic drugs (AEDs): is it an issue?
Bialer M
Epilepsia; 2007 Oct; 48(10):1825-32. PubMed ID: 17850324
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation and duration of antiepileptic drug therapy: a retrospective study of factors for specific epileptic syndromes.
Kudo T; Nishida T; Yagi K
Epilepsia; 2004; 45 Suppl 8():26-32. PubMed ID: 15610191
[TBL] [Abstract][Full Text] [Related]
18. Generic substitution in the treatment of epilepsy: patient and physician perceptions.
Berg MJ; Gross RA; Haskins LS; Zingaro WM; Tomaszewski KJ
Epilepsy Behav; 2008 Nov; 13(4):693-9. PubMed ID: 18589000
[TBL] [Abstract][Full Text] [Related]
19. Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization.
Manjunath R; Paradis PE; Parisé H; Lafeuille MH; Bowers B; Duh MS; Lefebvre P; Faught E
Neurology; 2012 Oct; 79(18):1908-16. PubMed ID: 23077014
[TBL] [Abstract][Full Text] [Related]
20. Risk of aplastic anemia in patients using antiepileptic drugs.
Handoko KB; Souverein PC; van Staa TP; Meyboom RH; Leufkens HG; Egberts TC; van den Bemt PM
Epilepsia; 2006 Jul; 47(7):1232-6. PubMed ID: 16886988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
